Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.02−0.09 (-8.11%)
Close on Nov 17, 2026Market cap $172.94MP/E –Yield –
Cabaletta Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cabaletta Bio's market cap was $300.43M on Apr 30, 2026, against $116.75M a year earlier. Over the last 5 years it ranged from $18.86M to $1.09B, with a median of $261.56M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Apr 30, 2026 | $300.43M | +42.5% |
| 2025 | Dec 31, 2025 | $210.82M | +90.1% |
| 2024 | Dec 31, 2024 | $110.89M | -88.3% |
| 2023 | Dec 29, 2023 | $945.69M | +252.4% |
| 2022 | Dec 30, 2022 | $268.38M | +155.3% |
| 2021 | Dec 31, 2021 | $105.10M | -65.0% |
| 2020 | Dec 31, 2020 | $300.21M | +458.4% |
| 2019 | Dec 31, 2019 | $53.76M | – |
See a number that looks wrong?